🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-527015-42-00
Authorised Phase I

Study of the distribution of linezolid in the prostate in patients who underwent endoscopic prostate enucleation – DiProLine

2026-527015-42-00 · tracked via the Priya Life Science EU tracker
Sponsor
Centre Hospitalier Le Mans
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Male Urogenital Diseases
Decision date
14/09/2026
Enrollment target
27
Sites
France

Condition studied

A Study of the Distribution of Linezolid in the Prostate in Patients Who Underwent Endoscopic Prostatectomy.

Eligibility

Age group
65+ years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-527015-42-00 on CTIS ↗ ← All trials in the EU